Exact Mass: 634.3417

(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside

C34H50O11 (634.3353)

(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside is found in fruits. (3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside is a constituent of Physalis peruviana (Cape gooseberry).

2alpha-Hydroxypyracrenic acid

C39H54O7 (634.3869)

2alpha-Hydroxypyracrenic acid is found in fruits. 2alpha-Hydroxypyracrenic acid is a constituent of Zizyphus jujuba (Chinese date) Constituent of Zizyphus jujuba (Chinese date). 2alpha-Hydroxypyracrenic acid is found in fruits.

3-trans-p-Coumaroylrotundic acid

C39H54O7 (634.3869)

3-trans-p-Coumaroylrotundic acid is found in fruits. 3-trans-p-Coumaroylrotundic acid is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). 3-trans-p-Coumaroylrotundic acid is found in loquat and fruits.

Digitoxigenin bisdigitoxide

C35H54O10 (634.3717)

2-(4-Hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate

C30H55N2O8PS (634.3417)

PA(10:0/5-iso PGF2VI)

C31H55O11P (634.3482)

PA(10:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/5-iso PGF2VI), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(5-iso PGF2VI/10:0)

C31H55O11P (634.3482)

PA(5-iso PGF2VI/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/10:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/PGF2alpha)

C31H55O11P (634.3482)

PA(8:0/PGF2alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGF2alpha), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGF2alpha/8:0)

C31H55O11P (634.3482)

PA(PGF2alpha/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF2alpha/8:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/PGE1)

C31H55O11P (634.3482)

PA(8:0/PGE1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGE1), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE1/8:0)

C31H55O11P (634.3482)

PA(PGE1/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE1/8:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/PGD1)

C31H55O11P (634.3482)

PA(8:0/PGD1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGD1), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD1/8:0)

C31H55O11P (634.3482)

PA(PGD1/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD1/8:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Myriceric acid B

C39H54O7 (634.3869)

trans-3beta-Caffeoyloxy-2alpha-hydroxyurs-12-en-28-oic acid

C39H54O7 (634.3869)

Madlongiside A

C35H54O10 (634.3717)

Guavacoumaric acid

C39H54O7 (634.3869)

Hippuristerone J

C35H54O10 (634.3717)

Oxamicetin

C29H42N6O10 (634.2962)

Bugbanoside F

C35H54O10 (634.3717)

Manauealide C

C34H50O11 (634.3353)

Capuvosine

C40H50N4O3 (634.3883)

Unnarmicin A

C36H50N4O6 (634.373)

3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxahentetracontane-1,41-diol

C28H58O15 (634.3776)

(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid

C35H54O10 (634.3717)

3-O-Coumaroylarjunolic acid

C39H54O7 (634.3869)

jaspamide O

C35H46N4O7 (634.3366)

A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.

3-(3-hydroxy-5,18-seco-ibogamin-12-yl)-vobasan-17-oic acid methyl ester|Capuvosin

C40H50N4O3 (634.3883)

23-cis-p-coumaroyloxy-2alpha,3alpha-dihydroxyolean-12-en-28-oic acid

C39H54O7 (634.3869)

DTXSID00963186

C34H50O11 (634.3353)

Dregosid A

C35H54O10 (634.3717)

Isosungucine

C42H42N4O2 (634.3308)

3-O-p-Coumaroyltormentic acid

C39H54O7 (634.3869)

3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-poriferast-16-ene-15,23-dione|pandaroside B

C35H54O10 (634.3717)

C35H54O10

C35H54O10 (634.3717)

ajugatakasin B

C34H50O11 (634.3353)

A diterpene lactone isolated from the whole plants of Ajuga ciliata that is ajugatakasin A in which both of the 2-methylbutenoate ester goups have been hydrogenated to the corresponding 2-methylbutanoates.

3beta-cis-p-coumaroyloxy-2alpha,3beta,13beta-trihydroxy-urs-11-en-28-oic acid

C39H54O7 (634.3869)

C42H42N4O2

C42H42N4O2 (634.3308)

C39H54O7

C39H54O7 (634.3869)

dysoxin 1b

C39H54O7 (634.3869)

3beta,23-dihydroxy-lup-20(29)-en-28-oic acid 3beta-caffeate

C39H54O7 (634.3869)

bugbanoside B

C35H54O10 (634.3717)

3-O-??-D-Xylopyranosyl-esculentic acid

C35H54O10 (634.3717)

zygosporamide

C36H50N4O6 (634.373)

dichapetalin F

C39H54O7 (634.3869)

paucinone C

C38H50O8 (634.3506)

(3R,5beta,16S,17S,20R,22S,23S,24S,25S)-16,23:16,27:22,25-triepoxy-17-hydroxystigmast-7-en-3-yl beta-D-glucopyranoside|ajugasalicioside A

C35H54O10 (634.3717)

cherimolacyclopeptide E

C33H42N6O7 (634.3115)

didigitoxosyldigitoxigenin|digitoxigen O-[2,6-dideoxy-beta-D-ribo-hexopyranosyl]-(1->4)-(2,6-dideoxy-beta-D-ribo-hexopyranoside)|digitoxigenin 2,6-dideoxy-4-O-[2,6-dideoxy-beta-D-ribo-hexopyranosyl]-beta-D-ribo-hexopyranoside|digitoxigenin 3-O-beta-D-digitoxosyl-(1<*>4)-beta-D-digitoxoside|digitoxigenin bis-digitoxose|digitoxigenin bisdigitoxoside|digitoxigenin-3-O-beta-D-digitoxosyl-(1->4)-beta-D-digitoxoside

C35H54O10 (634.3717)

2-O-caffeoyl maslinic acid

C39H54O7 (634.3869)

A pentacyclic triterpenoid that is the 2-O-caffeoyl derivative of maslinic acid. It is isolated from the branch barks of Hippophae rhamnoides and acts as a radical scavenger.

caudatin 3-O-beta-cymaropyranoside

C35H54O10 (634.3717)

3beta-O-beta-D-glucopyranosyloxy-16beta,26,29-trihydroxy-5alpha-stigmasta-7,9(11),24(28)Z-trien-6-one

C35H54O10 (634.3717)

gnidilatidin

C37H46O9 (634.3142)

11,12,11,12-tetradehydro-[11,18]bi[12,23-seco-24-nor-strychnidine]-10,10-dione|Sangucin|sungucine

C42H42N4O2 (634.3308)

(22R)-27-hydroxy-7alpha-methoxy-1-oxowitha-3,5,24-trienolide

C35H54O10 (634.3717)

2alpha-O-trans-p-coumaroyl-3beta,19alpha-dihydroxy-urs-12-en-28-oic acid

C39H54O7 (634.3869)

C34H50O11

C34H50O11 (634.3353)

glaucacetalin A

C34H50O11 (634.3353)

3beta-O-trans-caffeoyl-2alpha-hydroxyolean-12-en-28-oic acid

C39H54O7 (634.3869)

28-O-trans-caffeoyl-3beta,28-dihydroxy-20(29)-lupen-27-oic acid

C39H54O7 (634.3869)

3,8,14,20-Tetraacetyl-7-(2-methylbutanoyl)-synadenol

C33H46O12 (634.2989)

aquoside B

C31H54O13 (634.3564)

(3beta,5alpha,11alpha,12beta,14beta)-12-acetoxy-3-[(2,6-dideoxy-4-O-methyl-beta-D-arabino-hexopyranosyl)oxy]-20-oxo-8,14-epoxypregnan-11-yl 2-methylbutanoate|3-O-olivomosyl-11-O-(2-methylbutanoyl)-12beta-O-acetyl-tenacigenin B|tenacigenoside B

C35H54O10 (634.3717)

30-(4-Hydroxycinnamoyl)-(3alpha,21beta)-3,21,24,30-Tetrahydroxy-14-serraten-16-one

C39H54O7 (634.3869)

Cimicifugoside H2

C35H54O10 (634.3717)

3beta,23-dihydroxy-olean-12-en-28-oic acid 23-caffeate

C39H54O7 (634.3869)

3beta,23-dihydroxy-olean-12-en-28-oic acid 3beta-caffeate

C39H54O7 (634.3869)

Queretaroic-30-caffeat

C39H54O7 (634.3869)

23(R),24(S),25(R),26(S)-16beta/23,23/26,24/25-triepoxy-6alpha,26-dihydroxy-9,9-cyclolanosta-3-O-beta-xyloside|bicusposide C

C35H54O10 (634.3717)

2alpha,3beta,23-trihydroxy-30-norolean-12-en-28-oic acid beta-D-glucopyranosyl ester|2alpha,3beta,23-trihydroxy-30-norolean-12-en-28-oic acid monoglycoside|Mutangsaponin A

C35H54O10 (634.3717)

24-Hydroxy-15,16-seco-cycloart-7-en 3-O-xyloside

C35H54O10 (634.3717)

Muscaroside L

C35H54O10 (634.3717)

3beta-[(alpha-L-arabinopyranosyl)oxy]-11alpha,12alpha-epoxy-13beta,16alpha,23-trihydroxyoleanan-28-oic acid gamma-lactone

C35H54O10 (634.3717)

Thr Val Glu Thr Trp

C29H42N6O10 (634.2962)

Phe Ile Asp Leu Asn

C30H46N6O9 (634.3326)

Val Met Met Val Arg

C26H50N8O6S2 (634.3295)

Asp Ile Lys Glu Met

C26H46N6O10S (634.2996)

3-O-cis-p-Coumaroyltormentic acid

C39H54O7 (634.3869)

Cimicifugoside H2

C35H54O10 (634.3717)

Cimicifugoside h 2 is a triterpenoid. Cimicifugoside H-2 is a natural product found in Actaea elata, Actaea cimicifuga, and other organisms with data available.

Olean-12-ene-23,28-dioic acid, 16-hydroxy-3-(beta-D-xylopyranosyloxy)-, (3beta,5xi,9xi,16alpha)

C35H54O10 (634.3717)

NCGC00347421-02_C35H54O10

Sungucine

C42H42N4O2 (634.3308)

(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid_major

C35H54O10 (634.3717)

(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid_minor

C35H54O10 (634.3717)

His His Arg Trp

C29H38N12O5 (634.3088)

His His Trp Arg

C29H38N12O5 (634.3088)

His Arg His Trp

C29H38N12O5 (634.3088)

His Arg Trp His

C29H38N12O5 (634.3088)

His Trp His Arg

C29H38N12O5 (634.3088)

His Trp Arg His

C29H38N12O5 (634.3088)

Ile Met Trp Trp

C33H42N6O5S (634.2937)

Ile Trp Met Trp

C33H42N6O5S (634.2937)

Ile Trp Trp Met

C33H42N6O5S (634.2937)

Leu Met Trp Trp

C33H42N6O5S (634.2937)

Leu Trp Met Trp

C33H42N6O5S (634.2937)

Leu Trp Trp Met

C33H42N6O5S (634.2937)

Met Ile Trp Trp

C33H42N6O5S (634.2937)

Met Leu Trp Trp

C33H42N6O5S (634.2937)

Met Trp Ile Trp

C33H42N6O5S (634.2937)

Met Trp Leu Trp

C33H42N6O5S (634.2937)

Met Trp Trp Ile

C33H42N6O5S (634.2937)

Met Trp Trp Leu

C33H42N6O5S (634.2937)

Digitoxigenin bisdigitoxoside

C35H54O10 (634.3717)

Arg His His Trp

C29H38N12O5 (634.3088)

Arg His Trp His

C29H38N12O5 (634.3088)

Arg Trp His His

C29H38N12O5 (634.3088)

Trp His His Arg

C29H38N12O5 (634.3088)

Trp His Arg His

C29H38N12O5 (634.3088)

Trp Ile Met Trp

C33H42N6O5S (634.2937)

Trp Ile Trp Met

C33H42N6O5S (634.2937)

Trp Leu Met Trp

C33H42N6O5S (634.2937)

Trp Leu Trp Met

C33H42N6O5S (634.2937)

Trp Met Ile Trp

C33H42N6O5S (634.2937)

Trp Met Leu Trp

C33H42N6O5S (634.2937)

Trp Met Trp Ile

C33H42N6O5S (634.2937)

Trp Met Trp Leu

C33H42N6O5S (634.2937)

Trp Arg His His

C29H38N12O5 (634.3088)

Trp Trp Ile Met

C33H42N6O5S (634.2937)

Trp Trp Leu Met

C33H42N6O5S (634.2937)

Trp Trp Met Ile

C33H42N6O5S (634.2937)

Trp Trp Met Leu

C33H42N6O5S (634.2937)

DIKEM

C26H46N6O10S (634.2996)

TVETW

C29H42N6O10 (634.2962)

VMMVR

C26H50N8O6S2 (634.3295)

Pandaroside B

C35H54O10 (634.3717)

2a-Hydroxypyracrenic acid

C39H54O7 (634.3869)

1,4,7-Heptanetriol

C34H50O11 (634.3353)

Magnesium ethylate

C39H54O7 (634.3869)

PKDdiA-PA

C31H55O11P (634.3482)

12-beta-acetoxy-3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloart-7-en-23-one-3-O-beta-D-xylopyranoside

C34H50O11 (634.3353)

TRAP-5 trifluoroacetate salt

C30H50N8O7 (634.3802)

1,4-bis(diethoxyphosphorylmethyl)-2,5-dioctoxybenzene

C32H60O8P2 (634.3763)

(R,R)-(-)N,N-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride

C36H52ClMnN2O2 (634.3098)

2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide

C34H55BrN2O4 (634.3345)

2-(4-Hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate

C30H55N2O8PS (634.3417)

caudatin-3-O-beta-cymaropyranoside

C35H54O10 (634.3717)

A steroid glycoside that is 3,8,12,14,17-pentahydroxypregn-5-en-20-one esterified at position 12 by (2E)-3,4-dimethylpent-2-enoic acid and glycosylated at the 3beta-hydroxy group by beta-cymaropyranose (the 3beta,12beta,14beta,17alpha stereoisomer). It is isolated from the roots of Cynanchum auriculatum and displays antineoplastic activity.

Card-20(22)-enolide, 3-[[2,6-dideoxy-4-O-(2,6-dideoxy-beta-D-ribo-hexopyranosyl)-beta-D-ribo-hexopyranosyl]oxy]-14-hydroxy-, (3beta,5beta)-

C35H54O10 (634.3717)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

PA(8:0/PGF2alpha)

C31H55O11P (634.3482)

PA(PGF2alpha/8:0)

C31H55O11P (634.3482)

PA(8:0/PGE1)

C31H55O11P (634.3482)

PA(PGE1/8:0)

C31H55O11P (634.3482)

PA(8:0/PGD1)

C31H55O11P (634.3482)

PA(PGD1/8:0)

C31H55O11P (634.3482)

PA(10:0/5-iso PGF2VI)

C31H55O11P (634.3482)

PA(5-iso PGF2VI/10:0)

C31H55O11P (634.3482)

2-[[(2R)-3-acetyloxy-2-[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

2-[[(2R)-2-acetyloxy-3-[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

2-[[(2R)-3-acetyloxy-2-[(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

2-[[(2R)-2-acetyloxy-3-[(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

2-[[(2R)-3-acetyloxy-2-[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

2-[[(2R)-2-acetyloxy-3-[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO11P+ (634.3356)

3-O-trans-p-coumaroyltormentic acid

C39H54O7 (634.3869)

A natural product found in Ficus mucuso.

withalongolide I

C34H50O11 (634.3353)

A withanolide saponin that consists of 3-hydroxy-22,26-epoxyergosta-5,24-diene substituted by additonal hydroxy groups at positions 19 and 27, oxo groups at positions 1 and 26 and a beta-D-glucopyranosyl residue at position 3 via a glycodic linkage. It has been isolated from Physalis longifolia.

Pilsicainide hydrochloride hydrate

C34H52Cl2N4O3 (634.3416)

D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators

(1R,13R,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

2-{3-[2-tert-butyl-7-(diethylamino)-4H-chromen-4-ylidene]prop-1-en-1-yl}-1-(5-carboxypentyl)-3,3-dimethyl-3H-indolium-5-sulfonate

C36H46N2O6S (634.3076)

(1R,13S,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,11-tetraen-9-one

C42H42N4O2 (634.3308)

2-{3-[4-tert-butyl-7-(diethylamino)-2H-chromen-2-ylidene]prop-1-en-1-yl}-1-(5-carboxypentyl)-3,3-dimethyl-3H-indolium-5-sulfonate

C36H46N2O6S (634.3076)

(1R,12S,13R,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

Smgdg O-18:4_3:0

C30H50O12S (634.3023)

Smgdg O-16:4_5:0

C30H50O12S (634.3023)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C35H54O10 (634.3717)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C32H59O10P (634.3846)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C32H59O10P (634.3846)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C32H59O10P (634.3846)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C32H59O10P (634.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate

C32H59O10P (634.3846)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C32H59O10P (634.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C32H59O10P (634.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C32H59O10P (634.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C32H59O10P (634.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C32H59O10P (634.3846)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate

C32H59O10P (634.3846)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C32H59O10P (634.3846)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H55O8P (634.3634)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H55O8P (634.3634)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H55O8P (634.3634)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate

C35H55O8P (634.3634)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H55O8P (634.3634)

[1-[(E)-dec-4-enoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C35H54O10 (634.3717)

[1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C32H59O10P (634.3846)

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C35H54O10 (634.3717)

2alpha-Hydroxypyracrenic acid

C39H54O7 (634.3869)

3-trans-p-Coumaroylrotundic acid

C39H54O7 (634.3869)

(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside

C34H50O11 (634.3353)

MGDG O-26:7;O

C35H54O10 (634.3717)

SMGDG O-21:4

C30H50O12S (634.3023)

SQDG 21:3

C30H50O12S (634.3023)

DGMG 15:3

C30H50O14 (634.32)

SQMG 22:3

C31H54O11S (634.3387)

DGGA 25:6

C34H50O11 (634.3353)

MGGA 26:6

C35H54O10 (634.3717)

PA O-18:0/11:3;O3

C32H59O10P (634.3846)

PA O-29:3;O3

C32H59O10P (634.3846)

PA 16:0/12:3;O3

C31H55O11P (634.3482)

PA 16:1/12:2;O3

C31H55O11P (634.3482)

PA 20:0/8:3;O3

C31H55O11P (634.3482)

PA 20:1/8:2;O3

C31H55O11P (634.3482)

PA 20:1/9:1;O2

C32H59O10P (634.3846)

PA 22:0/7:2;O2

C32H59O10P (634.3846)

PA 29:2;O2

C32H59O10P (634.3846)

PA 16:3_16:4

C35H55O8P (634.3634)

LPGP 21:0

C27H56O12P2 (634.3247)

LPGP O-22:0

C28H60O11P2 (634.3611)

PG O-16:0/9:4;O2

C31H55O11P (634.3482)

PG O-18:0/8:3;O

C32H59O10P (634.3846)

PG O-24:5;O3

C30H51O12P (634.3118)

PG O-25:4;O2

C31H55O11P (634.3482)

PG O-26:3;O

C32H59O10P (634.3846)

PG P-16:1/8:3;O3

C30H51O12P (634.3118)

PG P-18:0/7:3;O2

C31H55O11P (634.3482)

PG P-18:1/7:2;O2

C31H55O11P (634.3482)

PG P-18:1/8:1;O

C32H59O10P (634.3846)

PG P-20:0/6:2;O

C32H59O10P (634.3846)

PG 14:1/11:2;O

C31H55O11P (634.3482)

PG 16:1/8:3;O2

C30H51O12P (634.3118)

PG 18:0/7:3;O

C31H55O11P (634.3482)

PG 20:2/5:1;O

C31H55O11P (634.3482)

PG 20:3/4:1;O2

C30H51O12P (634.3118)

PG 24:4;O2

C30H51O12P (634.3118)

PG 25:3;O

C31H55O11P (634.3482)

PG 2:0_24:2

C32H59O10P (634.3846)

PG 22:1/4:1

C32H59O10P (634.3846)

PG 22:2/4:0

C32H59O10P (634.3846)

PG 26:2

C32H59O10P (634.3846)

PEth 29:8;O

C34H51O9P (634.3271)

PEth 30:7

C35H55O8P (634.3634)

PM 30:8;O

C34H51O9P (634.3271)

PM 31:7

C35H55O8P (634.3634)

ST 24:0;O8;GlcA

C30H50O14 (634.32)

ST 27:5;O6;GlcA

C33H46O12 (634.2989)

ST 28:4;O5;GlcA

C34H50O11 (634.3353)

ST 29:3;O4;GlcA

C35H54O10 (634.3717)

ST 25:0;O8;Hex

C31H54O13 (634.3564)

ST 27:6;O7;Hex

C33H46O12 (634.2989)

ST 28:5;O6;Hex

C34H50O11 (634.3353)

ST 29:4;O5;Hex

C35H54O10 (634.3717)

9-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O7 (634.3869)

1-{13-hydroxy-3-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-9-yl}ethyl acetate

C34H50O11 (634.3353)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C35H54O10 (634.3717)

(1r,2r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-1-[(2s)-6-methyl-3-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

C35H54O10 (634.3717)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

11-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14br)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

2-{[2,16-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol

C35H54O10 (634.3717)

11-hydroxy-9-(hydroxymethyl)-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

2-{[5-(3-hydroxy-3-methylpent-4-en-1-yl)-1-(hydroxymethyl)-1,4a,6-trimethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-hexahydro-2h-naphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C31H54O13 (634.3564)

(2s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid

C35H54O10 (634.3717)

23-trans-p-coumaroyloxy-2α,3β-dihydroxy-olean-12-en-28-oicacid

C39H54O7 (634.3869)

{"Ingredient_id": "HBIN004178","Ingredient_name": "23-trans-p-coumaroyloxy-2\u03b1,3\u03b2-dihydroxy-olean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)COC(=O)C=CC6=CC=C(C=C6)O)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4180","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3β-cis-p-coumaroyloxy-2α,23-dihydroxyolean-12-en-28-oicacid

C39H54O7 (634.3869)

{"Ingredient_id": "HBIN008195","Ingredient_name": "3\u03b2-cis-p-coumaroyloxy-2\u03b1,23-dihydroxyolean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)OC(=O)C=CC6=CC=C(C=C6)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4179","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(3 e)-coumaroylarjunolicacid

C39H54O7 (634.3869)

{"Ingredient_id": "HBIN008458","Ingredient_name": "(3 e)-coumaroylarjunolicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4151","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-beta-d-xylopyranosyl-esculentic acid

C35H54O10 (634.3717)

{"Ingredient_id": "HBIN009265","Ingredient_name": "3-o-beta-d-xylopyranosyl-esculentic acid","Alias": "3-o-\u03b2-d-xylopyranosyl-esculenticacid","Ingredient_formula": "C35H54O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32240;22806","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-O-cis-p-Coumaroyl tormentic acid

C39H54O7 (634.3869)

{"Ingredient_id": "HBIN009296","Ingredient_name": "3-O-cis-p-Coumaroyl tormentic acid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)O)C)C)C2C1(C)O)C)C(=O)O","Ingredient_weight": "634.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37795","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "133562427","DrugBank_id": "NA"}

(2s,3s,4s,5r,6r)-6-{[(3ar,3br,5as,7s,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-6-methyl-4-oxoheptan-2-yl]-2-hydroxy-9a,11a-dimethyl-3-oxo-3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H54O10 (634.3717)

2-{4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane]-4,15'-dioloxy}oxane-3,4,5-triol

C35H54O10 (634.3717)

(1s)-1-[(1r,3r,4s,5r,9r,13s,14r)-13-hydroxy-3-[(2r,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-9-yl]ethyl acetate

C34H50O11 (634.3353)

(1r,2s,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl (4as,6as,6br,8r,8ar,9r,10r,12ar,12br,14bs)-8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-11-oxo-3,4,5,6,7,8,8a,10,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylate

C35H54O10 (634.3717)

10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

11-hydroxy-9-(hydroxymethyl)-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(2s)-5-[(2s)-n,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(n-hydroxyacetamido)-2-(methylamino)pentylidene]amino}propanamido]-n-[(1s)-2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-2-(methylamino)pentanimidic acid

C25H46N8O11 (634.3286)

14-ethylidene-10-{14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl}-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

(1s,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

5-(acetyloxy)-5-{3'-[(acetyloxy)methyl]-2-hydroxy-9a,11a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2-hydroxy-2,3,4-trimethylpentyl acetate

C35H54O10 (634.3717)

(1s,2r,4as,6as,6br,8ar,9s,10s,12ar,12bs,14bs)-10-hydroxy-9-({[(2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6b,9,12a-pentamethyl-1,2,3,4,5,6,6a,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

9-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(2s,3r,4s,5s,6r)-2-{[(1s,3s,7r,9r,12s,13r,16s,17s,18r,19s,20s,21s,22s)-21-ethyl-17-hydroxy-12,16,18,22-tetramethyl-24,25,26-trioxaheptacyclo[18.4.1.1¹⁹,²².0¹,¹⁷.0³,¹⁶.0⁴,¹³.0⁷,¹²]hexacos-4-en-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H54O10 (634.3717)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4as,5r,6r,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1-(hydroxymethyl)-1,4a,6-trimethyl-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-hexahydro-2h-naphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C31H54O13 (634.3564)

(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-3a-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5a-carboxylic acid

C39H54O7 (634.3869)

(3s,6s,9r,12s,15s)-3,12-dibenzyl-5,8,11,14-tetrahydroxy-6,9,15-tris(2-methylpropyl)-1-oxa-4,7,10,13-tetraazacyclopentadeca-4,7,10,13-tetraen-2-one

C36H50N4O6 (634.373)

(1r,2s,3s,4s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-3'-[(acetyloxy)methyl]-2-hydroxy-9a,11a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate

C35H54O10 (634.3717)

12-benzyl-1,4,7,10,13-pentahydroxy-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C33H42N6O7 (634.3115)

(2r,4ar,6as,6br,8ar,10s,12ar,12br,14br)-2-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(1s,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,12s,13r,14e,17r,19s,21s)-14-ethylidene-17-[(1r,12s,13r,14e,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-10-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid

C35H54O10 (634.3717)

(1s,2s,3e,5r,7s,8s,9r,10e,12s,13s,14s)-2,8,13-tris(acetyloxy)-3-[(acetyloxy)methyl]-10-(hydroxymethyl)-6,6,14-trimethyl-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadeca-3,10-dien-9-yl (2r)-2-methylbutanoate

C33H46O12 (634.2989)

3a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5a-carboxylic acid

C39H54O7 (634.3869)

(6r)-6-[(1r)-1-[(1s,3ar,3br,7r,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H50O11 (634.3353)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4r,5s,6s)-3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C34H50O11 (634.3353)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2r,3r,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H54O7 (634.3869)

6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-5'-propanoyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,5a,7,8,9,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-3-one

C35H54O10 (634.3717)

(1s,2r,4as,6as,6br,8ar,9s,10s,12ar,12bs,14bs)-10-hydroxy-9-({[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6b,9,12a-pentamethyl-1,2,3,4,5,6,6a,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,12s,13r,14e,19s,21s)-14-ethylidene-10-[(1r,12r,13r,14e,17r,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

(4as,6ar,6br,8ar,12ar,12br,14bs)-6a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(1s,2r,4as,6as,6br,9s,10r,11r,12ar)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(1s,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-1,3a,3b-trihydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3,4-dimethylpent-2-enoate

C35H54O10 (634.3717)

(4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14br)-10,11-dihydroxy-9-({[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(1s,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-{[(2z)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,11-dihydroxy-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-9-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

2-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

methyl (1s,2s,3s,4r,5r,8r,13s,14s,17s,18r,20r,21r,22r,25s)-3,21-bis(acetyloxy)-2,13,20,25-tetrahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C34H50O11 (634.3353)

(1s,2r,4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,13r,14e,19s,21s)-14-ethylidene-10-[(1r,12s,13r,14e,17r,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one

C42H42N4O2 (634.3308)

(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl (4as,6as,6br,8r,8ar,9r,10r,12ar,12br,14bs)-8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-11-oxo-3,4,5,6,7,8,8a,10,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylate

C35H54O10 (634.3717)

15-(5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl)-18-hydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H54O10 (634.3717)

(1r)-1-[(1s,3r,4s,9r,13r,14r)-13-hydroxy-3-[(2r,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-9-yl]ethyl acetate

C34H50O11 (634.3353)

10,11-dihydroxy-9-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

14-ethylidene-17-{14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-10-yl}-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,11-tetraen-9-one

C42H42N4O2 (634.3308)

(1s,2r,4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

6-[1-(9a,11a-dimethyl-9-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H50O11 (634.3353)

(1r,2s,3as,3br,5ar,7s,9as,9br,11ar)-7-{[(2r,3r,4s,5r,6r)-3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C34H50O11 (634.3353)

10,11-dihydroxy-9-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,3as,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13br)-9-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O7 (634.3869)

(1s,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

3,4,5-trihydroxyoxan-2-yl 8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-11-oxo-3,4,5,6,7,8,8a,10,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylate

C35H54O10 (634.3717)

(1s,2s,4s,5r,6s,9s,10r,11r,14r,15s,17r,18r,23r)-17-hydroxy-10-(hydroxymethyl)-6,10,14,15,21,21-hexamethyl-9-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacosan-25-one

C35H54O10 (634.3717)

6-{[1-(5-ethyl-6-methyl-4-oxoheptan-2-yl)-2-hydroxy-9a,11a-dimethyl-3-oxo-3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H54O10 (634.3717)

(4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

methyl (3s)-3-[(3s,3as,5ar,6s,7s,9r,9ar)-9-(acetyloxy)-3-[(3s,5r,6s)-5,6-dihydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,9a-trimethyl-7-(prop-1-en-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]-3-(acetyloxy)propanoate

C35H54O10 (634.3717)

(1s,3'r,3as,5's,5ar,6s,7s,9as,11as)-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-5'-propanoyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,5a,7,8,9,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-3-one

C35H54O10 (634.3717)

(2s,3r,4s,5r)-2-[(1r,1's,2r,4'r,5s,5'r,6'r,10's,12's,13's,16's,18's,20's,21's)-4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane]-4,20'-dioloxy]oxane-3,4,5-triol

C35H54O10 (634.3717)

3-[(1r,4s)-4-[(1s,3r,4s,5s,9r,13s,14r)-13-hydroxy-9-[(1s)-1-hydroxyethyl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-3-yl]-1-methoxypentyl]phenyl acetate

C34H50O11 (634.3353)

(2s,3r,4s,5s)-2-{[(1s,2r,3s,7r,9s,12r,14s,16r,17r,18r,19r,21r,22s)-2,16-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol

C35H54O10 (634.3717)

(1s,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O7 (634.3869)

3-(acetyloxy)-15-[5-(3,3-dimethyloxiran-2-yl)-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H54O7 (634.3869)

(3s,6s,8s,12r,15r,16r)-15-[(2r,5r)-5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl]-3-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-14-one

C35H54O10 (634.3717)

2-({[2-(3-carboxypropyl)-6-hydroxy-10-methoxy-9-methyl-3-oxo-1,4,8-trioxaspiro[4.5]decan-7-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C33H46O12 (634.2989)

6a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

7-{[3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C34H50O11 (634.3353)

(1r,13s,14e,17r,19s,21s)-14-ethylidene-17-[(1r,12s,13r,14e,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-10-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,11-tetraen-9-one

C42H42N4O2 (634.3308)

3,9-dibenzyl-5,8,11,14-tetrahydroxy-6,12-bis(2-methylpropyl)-16-propyl-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one

C36H50N4O6 (634.373)

methyl 6,7-dihydroxy-2-[(1s,2r,3r,5r,6r,9s,14s,15r,18r)-3-hydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-6-methyl-4-oxoheptanoate

C39H54O7 (634.3869)

methyl 3,21-bis(acetyloxy)-2,13,20,25-tetrahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C34H50O11 (634.3353)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C35H54O10 (634.3717)

(3r,6s,8s,12r,15r,16r)-15-[(2r,5r)-5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl]-3-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-14-one

C35H54O10 (634.3717)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(1r,2s,3s,4r)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-3'-[(acetyloxy)methyl]-2-hydroxy-9a,11a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate

C35H54O10 (634.3717)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2r)-2-methylbutanoate

C34H50O11 (634.3353)

(1r,2s,4r,5r,8r,9s,11r)-2-({[(2s,5r,6r,7r,9r,10r)-2-(3-carboxypropyl)-6-hydroxy-10-methoxy-9-methyl-3-oxo-1,4,8-trioxaspiro[4.5]decan-7-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C33H46O12 (634.2989)

(1s,2r,4as,6as,6br,8ar,9s,10s,12ar,12bs,14bs)-10-hydroxy-9-({[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6b,9,12a-pentamethyl-1,2,3,4,5,6,6a,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

17-hydroxy-10-(hydroxymethyl)-6,10,14,15,21,21-hexamethyl-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacosan-25-one

C35H54O10 (634.3717)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylbutanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylbutanoate

C34H50O11 (634.3353)

2-({21-ethyl-17-hydroxy-12,16,18,22-tetramethyl-24,25,26-trioxaheptacyclo[18.4.1.1¹⁹,²².0¹,¹⁷.0³,¹⁶.0⁴,¹³.0⁷,¹²]hexacos-4-en-9-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H54O10 (634.3717)

methyl 3-(acetyloxy)-3-[9-(acetyloxy)-3-[5,6-dihydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,9a-trimethyl-7-(prop-1-en-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoate

C35H54O10 (634.3717)

3,12-dibenzyl-5,8,11,14-tetrahydroxy-6,9,15-tris(2-methylpropyl)-1-oxa-4,7,10,13-tetraazacyclopentadeca-4,7,10,13-tetraen-2-one

C36H50N4O6 (634.373)

(6r)-6-[(1r)-1-[(1s,3as,3bs,7r,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H50O11 (634.3353)

1-acetyl-1,3a,3b-trihydroxy-7-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 3,4-dimethylpent-2-enoate

C35H54O10 (634.3717)

3-{4-[13-hydroxy-9-(1-hydroxyethyl)-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-3-yl]-1-methoxypentyl}phenyl acetate

C34H50O11 (634.3353)

(6s,12s,15s,20as)-12-benzyl-1,4,7,10,13-pentahydroxy-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C33H42N6O7 (634.3115)

(4as,6ar,6br,8ar,10s,12ar,12br,14bs)-6a-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(2s,3r,4s,5r)-2-[(1s,1's,2s,4s,4'r,5r,5'r,6'r,10's,12's,13's,15's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane]-4,15'-dioloxy]oxane-3,4,5-triol

C35H54O10 (634.3717)

2,8,13-tris(acetyloxy)-3-[(acetyloxy)methyl]-10-(hydroxymethyl)-6,6,14-trimethyl-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadeca-3,10-dien-9-yl 2-methylbutanoate

C33H46O12 (634.2989)

1,11-dihydroxy-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O7 (634.3869)

(3s,6s,9r,12s,16r)-3,9-dibenzyl-5,8,11,14-tetrahydroxy-6,12-bis(2-methylpropyl)-16-propyl-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one

C36H50N4O6 (634.373)

(2s,3r,4s,5s)-2-{[(2r,3s,7r,9s,12r,14s,16r,17r,18r,19r,21r,22s)-2,16-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol

C35H54O10 (634.3717)